Fingerprint
Dive into the research topics of 'Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
Myra Langendonk, Nienke A.M. Smit, Wouter Plattel, Arjan Diepstra, Tom van Meerten, Lydia Visser*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
4
Citations
(Scopus)
66
Downloads
(Pure)